Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
chailian ganmao granules
- Development stage
- Unknown
- Lead developer
- Kaken Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Chailian Ganmao Granules is a Traditional Chinese Medicine (TCM) formulation primarily used for the treatment of wind-heat type common cold and acute upper respiratory tract infections. Developed and manufactured by companies such as Wuhan Shuanglong Pharmaceutical, the granules are a combination of several herbal extracts, including *Bupleurum chinense* (Chaihu), *Scutellaria baicalensis* (Huangqin), and *Forsythia suspensa* (Lianqiao). Its mechanism of action involves antipyretic, anti-inflammatory, and antiviral properties, aimed at clearing heat and detoxifying the body (Jie Biao Qing Re, Xie Huo Jie Du). Pharmacologically, it works by inhibiting inflammatory mediators such as prostaglandin E2 (via COX-2 inhibition) and reducing the levels of pro-inflammatory cytokines like TNF-alpha and IL-6. It is indicated for symptoms including fever, headache, sore throat, and cough associated with wind-heat syndrome.
- Brand names
- Chailian Ganmao Granules
- Other names
- Chailian Ganmao Keli柴连感冒颗粒
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on chailian ganmao granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on chailian ganmao granules.